WTOP - 17 Feb 2022
Gaithersburg, Maryland-based Novavax, awaiting FDA approval for use of its COVID-19 vaccine in the U.S., receives approval from Canada.
Novavax Investor Relations - 11 Jun 2025
Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial ...